BC Innovations | Feb 6, 2018
Distillery Therapeutics

Infectious disease

INDICATION: Influenza virus Mouse studies suggest a protein nanoparticle vaccine based on M2e, HA1 and HA2 could help prevent influenza A virus infection. The vaccine consists of a mixture of nanoparticles, all having the same...
BC Innovations | Oct 12, 2017
Product R&D

Artificial mini proteins

Virvio Inc. has spun out of a group from the University of Washington to develop artificial mini proteins as novel influenza therapeutics. The mini proteins, typically ranging between 30 and 50 amino acids in length,...
BC Innovations | Jul 21, 2011
Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Influenza virus Influenza virus hemagglutinin 2 (HA2) In vitro and mouse studies suggest targeting a broadly neutralizing influenza epitope could help prevent or treat...
BC Week In Review | Jun 14, 2010
Company News

FluGen, WARF deal

The foundation granted FluGen exclusive, worldwide rights to develop and commercialize FG 101 to treat influenza. WARF will receive an undisclosed upfront payment and is eligible for undisclosed milestones and royalties. The peptide therapeutic that...
Items per page:
1 - 4 of 4